Updates on Weight Management Pharmacotherapy

The content will review available pharmacotherapy for obesity. There have been multiple updates in 2022 and 2023 including a pending approval for a new medication and several in the pipeline. There have also been several clinical implications for the GLP1s including drug shortages, compounding questions, mortality benefit findings, and coverage questions.